Terms: = Head and neck cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR
473 results:
1. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.
Govind K; Paruk IM; Motala AA
BMC Endocr Disord; 2024 Apr; 24(1):53. PubMed ID: 38664758
[TBL] [Abstract] [Full Text] [Related]
2. Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening.
Nofal S; Niu J; Resong P; Jin J; Merriman KW; Le X; Katki H; Heymach J; Antonoff MB; Ostrin E; Wu J; Zhang J; Toumazis I
Cancer Med; 2024 Mar; 13(5):e7069. PubMed ID: 38466021
[TBL] [Abstract] [Full Text] [Related]
3. 3D-IncNet: head and neck (H&N) Primary Tumors Segmentation and Survival Prediction.
Qayyum A; Benzinou A; Razzak I; Mazher M; Nguyen TT; Puig D; Vafaee F
IEEE J Biomed Health Inform; 2024 Mar; 28(3):1185-1194. PubMed ID: 38446658
[TBL] [Abstract] [Full Text] [Related]
4. Prevalence of thyroid diffuse goiter and its association with body mass index and the presence of cysts and nodules in children and adolescents: the Fukushima Health Management Survey.
Nakahata N; Asano M; Abe N; Ejiri H; Ota H; Suzuki S; Sato A; Tazaki R; Nagamine N; Takahashi C; Yamaya Y; Iwadate M; Matsuzuka T; Ohira T; Yasumura S; Suzuki S; Furuya F; Shimura H; Suzuki S; Yokoya S; Ohto H; Kamiya K
Endocr J; 2024 Apr; 71(4):383-393. PubMed ID: 38369332
[TBL] [Abstract] [Full Text] [Related]
5. Nomogram for predicting electrocoagulation syndrome after endoscopic submucosal dissection of esophageal tumors.
Liao F; Shen Z; Rong J; Zhu Z; Pan X; Wang C; Long S; Zhou X; Li G; Zhu Y; Chen Y; Shu X
Surg Endosc; 2024 Apr; 38(4):1877-1883. PubMed ID: 38307960
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of the Therapeutic Efficacy and Technical Outcomes between Conventional Fixed Electrodes and Adjustable Electrodes in the Radiofrequency Ablation of Benign Thyroid Nodules.
Shin JH; Seo M; Lee MK; Jung SL
Korean J Radiol; 2024 Feb; 25(2):199-209. PubMed ID: 38288899
[TBL] [Abstract] [Full Text] [Related]
7. Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.
Hosonuma M; Hirasawa Y; Kuramasu A; Murayama M; Narikawa Y; Toyoda H; Baba Y; Isobe J; Funayama E; Tajima K; Shida M; Hamada K; Tsurui T; Ariizumi H; Ishiguro T; Suzuki R; Ohkuma R; Kubota Y; Horiike A; Sambe T; Tsuji M; Wada S; Kiuchi Y; Kobayashi S; Tsunoda T; Yoshimura K
Cancer Sci; 2024 Mar; 115(3):752-762. PubMed ID: 38254257
[TBL] [Abstract] [Full Text] [Related]
8. The Establishment and Verification of a Nomogram Model for Predicting the Overall Survival of Medullary Thyroid Carcinoma: An Analysis Based on the SEER Database.
Wang W; Wang X; Che G; Qiao J; Chen Z; Liu J
Curr Oncol; 2023 Dec; 31(1):84-96. PubMed ID: 38248091
[TBL] [Abstract] [Full Text] [Related]
9. Comparing pyrotinib with trastuzumab and pertuzumab with trastuzumab for HER2-positive metastatic breast cancer: a retrospective, multicenter analysis.
You S; Xie Y; Sang D; Luo T; Yuan P; Xu F; Wang B
Front Endocrinol (Lausanne); 2023; 14():1325540. PubMed ID: 38149099
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic role of pathologic status other than complete response after neoadjuvant therapy followed by surgery in esophageal squamous cell carcinoma.
Park SY; Lee J; Oh D; Sun JM; Yun J; Jeon YJ; Cho JH; Choi YS; Zo JI; Shim YM; Kim HK
Esophagus; 2024 Jan; 21(1):51-57. PubMed ID: 38082188
[TBL] [Abstract] [Full Text] [Related]
11. A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors.
Kang D; Liu S; Yuan X; Liu S; Zhang Z; He Z; Yin X; Mao H
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18215-18240. PubMed ID: 38078963
[TBL] [Abstract] [Full Text] [Related]
12. Construction and validation of a risk-scoring model to predict lymph node metastasis in T1b-T2 esophageal cancer.
Lin JP; Chen XF; Chen WJ; Wang PY; He H; Zhuang FN; Zhou H; Chen YJ; Wei WW; Liu SY; Wang F
Surg Endosc; 2024 Feb; 38(2):640-647. PubMed ID: 38012439
[TBL] [Abstract] [Full Text] [Related]
13. Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
Xu T; Zhu C; Song F; Zhang W; Yuan M; Pan Z; Huang P
BMC Cancer; 2023 Nov; 23(1):1131. PubMed ID: 37990304
[TBL] [Abstract] [Full Text] [Related]
14. Tryptophan metabolism regulates inflammatory macrophage polarization as a predictive factor for breast cancer immunotherapy.
Xue L; Wang C; Qian Y; Zhu W; Liu L; Yang X; Zhang S; Luo D
Int Immunopharmacol; 2023 Dec; 125(Pt B):111196. PubMed ID: 37972471
[TBL] [Abstract] [Full Text] [Related]
15. Incidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients - a multicenter study.
Agholme MB; Dahllöf G; Törlén JK; Majorana A; Brennan MT; von Bültzingslöwen I; Tan PL; Hu S; Sim YF; Hong C
Support Care Cancer; 2023 Nov; 31(12):702. PubMed ID: 37971651
[TBL] [Abstract] [Full Text] [Related]
16. A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
Ho AL; Foster NR; Deraje Vasudeva S; Katabi N; Antonescu CR; Frenette GP; Pfister DG; Erlichman C; Schwartz GK
Cancer; 2024 Mar; 130(5):702-712. PubMed ID: 37947157
[TBL] [Abstract] [Full Text] [Related]
17. Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.
Janjigian YY; Kawazoe A; Bai Y; Xu J; Lonardi S; Metges JP; Yanez P; Wyrwicz LS; Shen L; Ostapenko Y; Bilici M; Chung HC; Shitara K; Qin SK; Van Cutsem E; Tabernero J; Li K; Shih CS; Bhagia P; Rha SY;
Lancet; 2023 Dec; 402(10418):2197-2208. PubMed ID: 37871604
[TBL] [Abstract] [Full Text] [Related]
18. Quality Performance Indicators for the Surgical Management of Oesophageal cancer: A Systematic Literature Review.
Kulasegaran S; Wang Y; Woodhouse B; MacCormick A; Srinivasa S; Koea J
World J Surg; 2023 Dec; 47(12):3262-3269. PubMed ID: 37865917
[TBL] [Abstract] [Full Text] [Related]
19. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of the Efficiency of Induction and Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal cancer.
Buyukkor M; Tay F; Kurtulus A; Ates O
J Coll Physicians Surg Pak; 2023 Oct; 33(10):1141-1147. PubMed ID: 37804020
[TBL] [Abstract] [Full Text] [Related]
[Next]
